Editor's Note This study from the University of Florida Health, Gainesville, examines the complications, cost-utility, and value of a dedicated trauma-endovascular hybrid OR. A total of 292 trauma patients, who underwent immediate operative intervention at a Level I trauma center (106 before construction of a hybrid OR and 186 after…
Editor's Note The Joint Commission, on May 3, announced the revision of several of its elements of performance (EPs) for critical access hospitals to align with the Centers for Medicare and Medicaid Services’ (CMS’) Conditions of Participation (CoPs). The revisions primarily address restraint and seclusion, the complaint process, and unified…
This year, the OR Business Management Conference was held in Savannah, Georgia, and returned to its regular schedule of February. The intimate event was again a symbiotic blend between financial-, business-centric education and high-quality networking. The education offered to seasoned and new business leaders alike, perhaps more than previous years,…
Today’s chat is with Tracy Hoeft-Hoffman, MSN, MBA, RN, CASC, Administrator, Heartland Surgery Center, Kearney, Nebraska. Q: What is something that went right at your facility and/or that you are thankful for this year? What has gone right this year and makes our center so successful every year is the…
Editor's Note: Originally published in 2022, this session recap remains highly relevant as OR leaders continue to face renovation projects amid shifting technology, staffing demands, and infrastructure renovation needs. We have resurfaced it as part of our ongoing focus on capital planning and perioperative design—even years later, the fundamentals still…
Editor's Note On October 12, the Food and Drug Administration (FDA) amended the emergency use authorization (EUA) of the Moderna and Pfizer-BioNTech COVID-19 vaccines, Bivalent, to authorize their use as a single booster dose in younger groups, Health Purchasing News October 12 reports. The Moderna vaccine is now authorized for…
Editor's Note In this study from Harvard Medical School, Boston, researchers find that the COVID-19 pandemic was associated with shifts in the focus of industry payments for research to physicians and teaching hospitals and an immediate and sustained decline in payments for marketing. During the study period (2018 to 2021), 705,490…